Lars Schlotawa, MD, has been working as a consultant for paediatrics, child neurology and metabolic medicine at the University Medical Centre Goettingen, Germany since 2018. He specialises in rare, neurodegenerative and neurometabolic diseases in children with a particular interest in Lysosomal Diseases. His research expertise comprises development of therapeutic approaches for lysosomal diseases through high-throughput drug screening and elucidation of cellular details of disease pathology and identification of druggable targets as well as clinical research including natural disease history studies and interventional trials in a truly translational approach. He is also affiliated with the Fraunhofer Institute for Translational Medicine, Germany.
